Solamargine is primarily studied for its potential anticancer properties. It has shown effectiveness in inducing apoptosis, or programmed cell death, in various cancer cell lines, including liver, breast, and lung cancers. This makes it a promising candidate for developing new cancer therapies. Additionally, solamargine exhibits antimicrobial activity, particularly against certain bacteria and fungi, suggesting its use in treating infections. Research also explores its role in enhancing the efficacy of chemotherapy drugs, potentially reducing the required dosage and minimizing side effects. Furthermore, solamargine is being investigated for its anti-inflammatory properties, which could be beneficial in managing chronic inflammatory diseases. Its diverse biological activities make it a compound of significant interest in both pharmaceutical and medical research.